Pirenzepine
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171949This classification denotes an antimuscarinic agent with the molecular formula C19H21N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3G0285N20N, chemically known as 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one but generally known as pirenzepine, which bears US NIH Compound Identifier 4848. European Medicines Agency schedules Pirenzepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09904MIG. The term PIRENZEPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). World Health Organization schedules pirenzepine in its Anatomical Therapeutic Chemical (ATC) Classification. PIRENZEPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirenzepine under HS 29335995 and SITC 51576. As of Q4 2014, PIRENZEPINE remains the US FDA Preferred Term for this commodity. Pirenzepine bears US NLM identifiers UMLS ID C0031978 and NCI Concept Code C76002. SMILES: O=C(N1C2C(C(=O)[NH]C3C1NCCC3)CCCC2)CN1CCN(CC1)C.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.